Select your Country or Region

  • TargetMol | Compound LibraryArgentinaArgentina
  • TargetMol | Compound LibraryAustraliaAustralia
  • TargetMol | Compound LibraryAustriaAustria
  • TargetMol | Compound LibraryBelgiumBelgium
  • TargetMol | Compound LibraryBrazilBrazil
  • TargetMol | Compound LibraryBulgariaBulgaria
  • TargetMol | Compound LibraryCroatiaCroatia
  • TargetMol | Compound LibraryCyprusCyprus
  • TargetMol | Compound LibraryCzechCzech
  • TargetMol | Compound LibraryDenmarkDenmark
  • TargetMol | Compound LibraryEgyptEgypt
  • TargetMol | Compound LibraryEstoniaEstonia
  • TargetMol | Compound LibraryFinlandFinland
  • TargetMol | Compound LibraryFranceFrance
  • TargetMol | Compound LibraryGermanyGermany
  • TargetMol | Compound LibraryGreeceGreece
  • TargetMol | Compound LibraryHong KongHong Kong
  • TargetMol | Compound LibraryHungaryHungary
  • TargetMol | Compound LibraryIcelandIceland
  • TargetMol | Compound LibraryIndiaIndia
  • TargetMol | Compound LibraryIrelandIreland
  • TargetMol | Compound LibraryIsraelIsrael
  • TargetMol | Compound LibraryItalyItaly
  • TargetMol | Compound LibraryJapanJapan
  • TargetMol | Compound LibraryKoreaKorea
  • TargetMol | Compound LibraryLatviaLatvia
  • TargetMol | Compound LibraryLebanonLebanon
  • TargetMol | Compound LibraryMalaysiaMalaysia
  • TargetMol | Compound LibraryMaltaMalta
  • TargetMol | Compound LibraryMoroccoMorocco
  • TargetMol | Compound LibraryNetherlandsNetherlands
  • TargetMol | Compound LibraryNew ZealandNew Zealand
  • TargetMol | Compound LibraryNorwayNorway
  • TargetMol | Compound LibraryPolandPoland
  • TargetMol | Compound LibraryPortugalPortugal
  • TargetMol | Compound LibraryRomaniaRomania
  • TargetMol | Compound LibrarySingaporeSingapore
  • TargetMol | Compound LibrarySlovakiaSlovakia
  • TargetMol | Compound LibrarySloveniaSlovenia
  • TargetMol | Compound LibrarySpainSpain
  • TargetMol | Compound LibrarySwedenSweden
  • TargetMol | Compound LibrarySwitzerlandSwitzerland
  • TargetMol | Compound LibraryTaiwan,ChinaTaiwan,China
  • TargetMol | Compound LibraryThailandThailand
  • TargetMol | Compound LibraryTurkeyTurkey
  • TargetMol | Compound LibraryUnited KingdomUnited Kingdom
  • TargetMol | Compound LibraryUnited StatesUnited States
  • TargetMol | Compound LibraryOther CountriesOther Countries
Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Dracaena

  • 3-Hydroxy-4',5-dimethoxystilbene
    TN294158436-29-6
    3-Hydroxy-4',5-dimethoxystilbene is a natural product of Dracaena, Liliaceae. The catalog number is TN2941 and the CAS number is 58436-29-6. 3-Hydroxy-4',5-dimethoxystilbene can be used as a reference standard.
    • $1,658
    Backorder
    Size
    QTY
    TargetMol | Inhibitor Sale
  • 7,4'-Dihydroxy-8-methylflavan
    TN321582925-55-1
    7,4'-Dihydroxy-8-methylflavan can significantly promote mesenchymal stem cells (MSCs) osteogenic differentiation by increasing the levels of alkaline phosphatase (ALP) activity. 7,4'-Dihydroxy-8-methylflavan also has free radical scavenging properties.
    • $350
    Backorder
    Size
    QTY
    TargetMol | Inhibitor Sale
  • 7-Hydroxy-3-(4-hydroxybenzyl)chroman
    TN32281180504-64-6
    7-Hydroxy-3-(4-hydroxybenzyl)chroman shows moderate inhibitory activity against a chymotrypsin-like activity of the proteasome.
    • $550
    Backorder
    Size
    QTY
    TargetMol | Inhibitor Sale
  • Obtucarbamate B
    TN603720913-18-2
    Obtucarbamate B has antitussive activity.
    • $550
    Backorder
    Size
    QTY
  • Obtucarbamate A
    TN20036935-99-5
    Obtucarbamate A isolated from Disporum cantoniense has antitussive activity.It has antitussive activity, it exhibits significant inhibitory effect against neuroinflammation with the IC50 value of 10.57 μM .
    • $83
    In Stock
    Size
    QTY
  • 4',5-Dihydroxyflavone
    T82606665-67-4
    4',5-Dihydroxyflavone is a soybean LOX-1(Ki: 102.6 μM) and yeast α-Glucosidase inhibitor (IC50: 66 μM).
    • $34
    In Stock
    Size
    QTY
  • Loureirin A
    T5S0896119425-89-7
    Loureirin A has an inhibitory effect on platelet activation, perhaps through an impairment of PI3K/Akt signaling.Loureirin A negatively affects agonist-induced platelet aggregation such as collagen, collagen-related peptide (CRP), ADP and thrombin. Lourei
    • $68
    In Stock
    Size
    QTY
  • Mannioside A
    TN44931038922-95-0
    Mannioside A has anti-inflammatory activity, inhibits carrageenan-induced paw edema in the rat.
    • $250
    Backorder
    Size
    QTY
  • Loureirin C
    TN1054116384-24-8
    Loureirin C can inhibit the activities of thrombin in vitro effectively.
    • $97
    In Stock
    Size
    QTY
  • Loureirin B
    T3876119425-90-0
    Loureirin B can downregulate the expression of fibrosis-related molecules by regulating MMPs and TIMPs levels, inhibit scar fibroblast proliferation and suppress TGF-β1-induced fibrosis, during which TGF-β1/Smad2/3 pathway is likely involved.
    • $64
    In Stock
    Size
    QTY
  • 2,4,4'-Trihydroxydihydrochalcone
    TN270715097-74-2
    2,4,4'-Trihydroxydihydrochalcone is a natural product from Dracaena draco.
    • $460
    Backorder
    Size
    QTY